Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Titel:
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Auteur:
Schneeweiss, A. Chia, S. Hickish, T. Harvey, V. Eniu, A. Hegg, R. Tausch, C. Seo, J.H. Tsai, Y.-F. Ratnayake, J. McNally, V. Ross, G. Cortés, J.